IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,732,000 | -13.2% | 389,588 | 0.0% | 0.66% | -33.3% |
| Q2 2022 | $4,301,000 | -33.7% | 389,588 | 0.0% | 0.98% | -35.9% |
| Q1 2022 | $6,487,000 | -12.8% | 389,588 | 0.0% | 1.53% | -37.4% |
| Q4 2021 | $7,437,000 | -22.6% | 389,588 | 0.0% | 2.45% | -29.8% |
| Q3 2021 | $9,607,000 | -27.0% | 389,588 | -23.0% | 3.49% | -35.4% |
| Q2 2021 | $13,163,000 | -26.5% | 505,890 | -10.6% | 5.41% | -28.3% |
| Q1 2021 | $17,916,000 | -31.8% | 565,890 | 0.0% | 7.55% | -19.6% |
| Q4 2020 | $26,257,000 | +33.6% | 565,890 | -5.2% | 9.39% | +12.8% |
| Q3 2020 | $19,650,000 | +18.5% | 596,890 | -1.2% | 8.32% | +12.6% |
| Q2 2020 | $16,577,000 | +12.7% | 603,890 | +22.9% | 7.39% | -17.1% |
| Q1 2020 | $14,710,000 | +17.1% | 491,390 | +8.3% | 8.92% | +17.2% |
| Q4 2019 | $12,564,000 | – | 453,890 | – | 7.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |